AI-Enhanced Immunoisolation Transplant System

Publication ID: 24-11856946_0008_PTD

Published: October 27, 2025

Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “AI-Enhanced Immunoisolation Transplant System,” Published Technical Disclosure No. 24-11856946_0008_PTD, Published October 27, 2025, available at https://archive.pr1or.art/24-11856946_0008_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,946.

Background and Problem Solved

The original patent disclosed a chamber for transplantation with a membrane for immunoisolation, addressing the limitation of immune reactions in transplantation. However, the original invention did not provide real-time monitoring, personalized treatment, or secure data management. The present invention solves these limitations by incorporating AI, IoT, blockchain, and micro-sensors to create a more comprehensive and efficient transplantation system.

Novelty and Inventive Step

The present invention's novelty lies in the synergistic combination of advanced technologies with the chamber for transplantation, enabling real-time monitoring, personalized treatment, and secure data management. The inventive step is the integration of these distinct technologies to create a more effective and efficient transplantation system.

Alternative Embodiments and Variations

Alternative embodiments of the invention could include the use of different AI algorithms, blockchain platforms, or micro-sensor arrays. Variations could also include the integration of other advanced technologies, such as robotics or nanotechnology, to further enhance the transplantation system.

Potential Commercial Applications and Market

The Synergistic Transplantation System has significant commercial potential in the healthcare industry, particularly in organ transplantation and regenerative medicine. The system's ability to provide personalized treatment, real-time monitoring, and secure data management could lead to improved transplantation outcomes and reduced healthcare costs.

CPC Classifications

Section	Class	Group
A	A01	A01N1/0231
B	B01	B01D63/089
A	A61	A61B2017/00969

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Biomedical engineering focusing on transplantation technologies, immunoisolation membranes, and medical device integration with advanced monitoring systems

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device specialist with expertise in cell transplantation, membrane technologies, sensor integration, and digital health monitoring systems, holding advanced degrees and practical experience in medical device development

Obviousness Rationale

A PHOSITA would recognize that integrating digital monitoring technologies with existing transplantation chambers represents a natural progression of medical device innovation. The source patent's fundamental immunoisolation chamber provides a clear technical foundation for incorporating advanced monitoring and data management technologies. These extensions represent predictable combinations of known techniques in medical device engineering that would be obvious to a skilled practitioner seeking to improve transplantation outcomes.

Obvious Combinations & Variations

Source Patent Element

Chamber for transplantation with immunoisolation membrane

PTD Variation

AI-powered monitoring device for tracking biological constituent's health

Obviousness Reasoning

Integrating real-time monitoring is a predictable solution for improving transplantation safety, using known sensor and machine learning technologies to extend the base immunoisolation concept

Source Patent Element

Membrane for preventing immune reactions

PTD Variation

Micro-sensor array for detecting biomarkers indicative of immune rejection

Obviousness Reasoning

Adding biomarker detection represents a logical enhancement to the immunoisolation technology, using standard sensor integration techniques to provide more comprehensive immune response monitoring

Source Patent Element

Transplantation chamber with selective membrane

PTD Variation

Blockchain-based secure patient data management system

Obviousness Reasoning

Implementing secure data management is a standard design improvement in medical technologies, representing a predictable application of existing digital security techniques to medical device ecosystems

Source Patent Element

Membrane-based transplantation chamber

PTD Variation

IoT-enabled communication module for real-time medical professional collaboration

Obviousness Reasoning

Integrating communication technologies is a routine enhancement in medical devices, representing a predictable extension of existing transplantation chamber technologies

Source Patent Element

Immunoisolation membrane for biological constituent protection

PTD Variation

Machine learning algorithms for generating personalized post-transplantation care recommendations

Obviousness Reasoning

Applying machine learning to medical device data represents a standard approach to improving treatment personalization, using known algorithmic techniques to extend the base transplantation technology

35 U.S.C. § 103 Summary: Based on US Patent 11856946's fundamental teachings of immunoisolation chambers, the present publication demonstrates that integrating digital monitoring, data management, and algorithmic analysis technologies represents an obvious extension of existing transplantation device technologies. A person having ordinary skill in the art would readily recognize these variations as predictable combinations of known techniques, thereby rendering potential derivative claims obvious and unpatentable.

Original Patent Information

Patent Number	US 11,856,946
Title	Chamber for transplantation and device for transplantation
Assignee(s)	FUJI ELECTRIC CO., LTD.